CEL-SCI Corporation (CVM)
USD 0.3
(43.2%)
USD 0.3
(43.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -31.47 Million USD | 12.72% |
| 2022 | -36.06 Million USD | 0.36% |
| 2021 | -36.19 Million USD | -24.87% |
| 2020 | -28.98 Million USD | -43.53% |
| 2019 | -20.19 Million USD | -20.41% |
| 2018 | -16.77 Million USD | 21.4% |
| 2017 | -21.33 Million USD | 16.49% |
| 2016 | -25.55 Million USD | 25.49% |
| 2015 | -34.29 Million USD | -24.38% |
| 2014 | -27.57 Million USD | -38.78% |
| 2013 | -19.86 Million USD | -15.23% |
| 2012 | -17.24 Million USD | 4.13% |
| 2011 | -17.98 Million USD | 3.1% |
| 2010 | -18.56 Million USD | -54.41% |
| 2009 | -12.02 Million USD | -26.37% |
| 2008 | -9.51 Million USD | -1.71% |
| 2007 | -9.35 Million USD | -74.83% |
| 2006 | -5.34 Million USD | -31.08% |
| 2005 | -4.08 Million USD | 1.07% |
| 2004 | -4.12 Million USD | -1.01% |
| 2003 | -4.08 Million USD | 35.14% |
| 2002 | -6.29 Million USD | 42.91% |
| 2001 | -11.02 Million USD | -29.45% |
| 2000 | -8.51 Million USD | -12.09% |
| 1999 | -7.6 Million USD | -7.04% |
| 1998 | -7.1 Million USD | 13.41% |
| 1997 | -8.2 Million USD | -28.13% |
| 1996 | -6.4 Million USD | -72.97% |
| 1995 | -3.7 Million USD | 19.57% |
| 1994 | -4.6 Million USD | -119.05% |
| 1993 | -2.1 Million USD | -50.0% |
| 1992 | -1.4 Million USD | -75.0% |
| 1991 | -800 Thousand USD | -33.33% |
| 1990 | -600 Thousand USD | 33.33% |
| 1989 | -900 Thousand USD | 35.71% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.07 Million USD | -9.1% |
| 2024 Q3 | -6.67 Million USD | 5.73% |
| 2024 Q1 | -6.48 Million USD | 13.15% |
| 2023 Q2 | -8.17 Million USD | -6.87% |
| 2023 Q4 | -7.46 Million USD | 8.73% |
| 2023 Q3 | -8.18 Million USD | -0.07% |
| 2023 FY | -31.47 Million USD | 12.72% |
| 2023 Q1 | -7.65 Million USD | 14.5% |
| 2022 Q3 | -8.71 Million USD | 8.72% |
| 2022 Q1 | -8.84 Million USD | -4.36% |
| 2022 Q2 | -9.55 Million USD | -8.01% |
| 2022 FY | -36.06 Million USD | 0.36% |
| 2022 Q4 | -8.94 Million USD | -2.62% |
| 2021 Q1 | -8.73 Million USD | -1.36% |
| 2021 Q2 | -8.53 Million USD | 2.27% |
| 2021 Q3 | -10.45 Million USD | -22.54% |
| 2021 FY | -36.19 Million USD | -24.87% |
| 2021 Q4 | -8.47 Million USD | 18.96% |
| 2020 Q4 | -8.61 Million USD | -24.66% |
| 2020 FY | -28.98 Million USD | -43.53% |
| 2020 Q3 | -6.9 Million USD | -3.71% |
| 2020 Q2 | -6.66 Million USD | 2.03% |
| 2020 Q1 | -6.8 Million USD | -20.48% |
| 2019 FY | -20.19 Million USD | -20.41% |
| 2019 Q1 | -5.03 Million USD | -40.44% |
| 2019 Q2 | -4.3 Million USD | 14.46% |
| 2019 Q3 | -5.21 Million USD | -20.98% |
| 2019 Q4 | -5.64 Million USD | -8.33% |
| 2018 Q2 | -4.2 Million USD | 14.37% |
| 2018 Q1 | -4.91 Million USD | -113.06% |
| 2018 Q3 | -4.07 Million USD | 3.22% |
| 2018 FY | -16.77 Million USD | 21.4% |
| 2018 Q4 | -3.58 Million USD | 11.93% |
| 2017 Q2 | -8.38 Million USD | -54.82% |
| 2017 FY | -21.33 Million USD | 16.49% |
| 2017 Q4 | -2.3 Million USD | 55.97% |
| 2017 Q1 | -5.41 Million USD | 23.89% |
| 2017 Q3 | -5.23 Million USD | 37.55% |
| 2016 FY | -25.55 Million USD | 25.49% |
| 2016 Q1 | -5.78 Million USD | 30.66% |
| 2016 Q4 | -7.11 Million USD | -11.45% |
| 2016 Q3 | -6.38 Million USD | -1.74% |
| 2016 Q2 | -6.27 Million USD | -8.48% |
| 2015 Q4 | -8.33 Million USD | -1.69% |
| 2015 FY | -34.29 Million USD | -24.38% |
| 2015 Q1 | -9.99 Million USD | -17.43% |
| 2015 Q3 | -8.2 Million USD | -5.7% |
| 2015 Q2 | -7.75 Million USD | 22.37% |
| 2014 FY | -27.57 Million USD | -38.78% |
| 2014 Q2 | -6.22 Million USD | -4.92% |
| 2014 Q3 | -6.9 Million USD | -10.84% |
| 2014 Q4 | -8.51 Million USD | -23.34% |
| 2014 Q1 | -5.93 Million USD | -17.01% |
| 2013 Q2 | -4.23 Million USD | 15.95% |
| 2013 FY | -19.86 Million USD | -15.23% |
| 2013 Q4 | -5.07 Million USD | 8.01% |
| 2013 Q3 | -5.51 Million USD | -30.03% |
| 2013 Q1 | -5.04 Million USD | -16.66% |
| 2012 Q1 | -4.44 Million USD | -19.22% |
| 2012 Q4 | -4.32 Million USD | -2.63% |
| 2012 Q3 | -4.21 Million USD | 1.16% |
| 2012 Q2 | -4.26 Million USD | 4.07% |
| 2012 FY | -17.24 Million USD | 4.13% |
| 2011 Q1 | -4.31 Million USD | 22.83% |
| 2011 Q4 | -3.72 Million USD | 23.09% |
| 2011 Q2 | -5.09 Million USD | -18.09% |
| 2011 FY | -17.98 Million USD | 3.1% |
| 2011 Q3 | -4.84 Million USD | 4.93% |
| 2010 Q2 | -5.32 Million USD | -25.1% |
| 2010 Q1 | -4.25 Million USD | -9.32% |
| 2010 Q3 | -3.39 Million USD | 36.21% |
| 2010 Q4 | -5.59 Million USD | -64.79% |
| 2010 FY | -18.56 Million USD | -54.41% |
| 2009 Q4 | -3.89 Million USD | -6.35% |
| 2009 Q3 | -3.65 Million USD | -70.74% |
| 2009 Q2 | -2.14 Million USD | 8.02% |
| 2009 FY | -12.02 Million USD | -26.37% |
| 2009 Q1 | -2.32 Million USD | 2.26% |
| 2008 FY | -9.51 Million USD | -1.71% |
| 2008 Q4 | -2.38 Million USD | -9.48% |
| 2008 Q1 | -2.86 Million USD | -44.57% |
| 2008 Q2 | -2.08 Million USD | 27.28% |
| 2008 Q3 | -2.17 Million USD | -4.39% |
| 2007 Q1 | -1.57 Million USD | 5.99% |
| 2007 FY | -9.35 Million USD | -74.83% |
| 2007 Q4 | -1.98 Million USD | 47.48% |
| 2007 Q3 | -3.77 Million USD | -87.63% |
| 2007 Q2 | -2.01 Million USD | -27.39% |
| 2006 Q2 | -1.34 Million USD | -31.25% |
| 2006 Q1 | -1.02 Million USD | -28.85% |
| 2006 FY | -5.34 Million USD | -31.08% |
| 2006 Q4 | -1.68 Million USD | -28.74% |
| 2006 Q3 | -1.3 Million USD | 2.67% |
| 2005 Q3 | -984.37 Thousand USD | 9.59% |
| 2005 Q2 | -1.08 Million USD | 10.35% |
| 2005 Q1 | -1.21 Million USD | -19.92% |
| 2005 FY | -4.08 Million USD | 1.07% |
| 2005 Q4 | -793.07 Thousand USD | 19.43% |
| 2004 Q4 | -1.01 Million USD | -11.61% |
| 2004 Q3 | -907.43 Thousand USD | 25.25% |
| 2004 Q2 | -1.21 Million USD | -22.57% |
| 2004 Q1 | -990.48 Thousand USD | 1.25% |
| 2004 FY | -4.12 Million USD | -1.01% |
| 2003 Q2 | -872.9 Thousand USD | 27.51% |
| 2003 Q1 | -1.2 Million USD | 1.8% |
| 2003 Q3 | -1 Million USD | -14.92% |
| 2003 FY | -4.08 Million USD | 35.14% |
| 2003 Q4 | -1 Million USD | 0.02% |
| 2002 Q1 | -2.88 Million USD | -2.79% |
| 2002 Q4 | -1.22 Million USD | -18.22% |
| 2002 Q3 | -1.03 Million USD | 9.72% |
| 2002 Q2 | -1.14 Million USD | 60.15% |
| 2002 FY | -6.29 Million USD | 42.91% |
| 2001 Q4 | -2.8 Million USD | -37.15% |
| 2001 Q1 | -2.54 Million USD | -70.48% |
| 2001 Q2 | -3.63 Million USD | -42.87% |
| 2001 Q3 | -2.04 Million USD | 43.72% |
| 2001 FY | -11.02 Million USD | -29.45% |
| 2000 Q2 | -2.88 Million USD | -69.69% |
| 2000 FY | -8.51 Million USD | -12.09% |
| 2000 Q1 | -1.7 Million USD | 15.0% |
| 2000 Q4 | -1.49 Million USD | 35.94% |
| 2000 Q3 | -2.32 Million USD | 19.27% |
| 1999 Q2 | -2.2 Million USD | -37.5% |
| 1999 Q3 | -1.7 Million USD | 22.73% |
| 1999 Q4 | -2 Million USD | -17.65% |
| 1999 FY | -7.6 Million USD | -7.04% |
| 1999 Q1 | -1.6 Million USD | 30.43% |
| 1998 FY | -7.1 Million USD | 13.41% |
| 1998 Q1 | -1.6 Million USD | -6.67% |
| 1998 Q2 | -1.3 Million USD | 18.75% |
| 1998 Q3 | -1.7 Million USD | -30.77% |
| 1998 Q4 | -2.3 Million USD | -35.29% |
| 1997 Q4 | -1.5 Million USD | 16.67% |
| 1997 Q2 | -3.6 Million USD | -227.27% |
| 1997 Q3 | -1.8 Million USD | 50.0% |
| 1997 FY | -8.2 Million USD | -28.13% |
| 1997 Q1 | -1.1 Million USD | 45.0% |
| 1996 Q3 | -1.5 Million USD | -25.0% |
| 1996 Q1 | -1.7 Million USD | -88.89% |
| 1996 FY | -6.4 Million USD | -72.97% |
| 1996 Q4 | -2 Million USD | -33.33% |
| 1996 Q2 | -1.2 Million USD | 29.41% |
| 1995 Q3 | -700 Thousand USD | 30.0% |
| 1995 Q1 | -1 Million USD | 9.09% |
| 1995 Q2 | -1 Million USD | 0.0% |
| 1995 Q4 | -900 Thousand USD | -28.57% |
| 1995 FY | -3.7 Million USD | 19.57% |
| 1994 Q2 | -900 Thousand USD | -50.0% |
| 1994 Q3 | -1.2 Million USD | -33.33% |
| 1994 Q4 | -1.1 Million USD | 8.33% |
| 1994 FY | -4.6 Million USD | -119.05% |
| 1994 Q1 | -600 Thousand USD | 33.33% |
| 1993 Q1 | -200 Thousand USD | 75.0% |
| 1993 Q4 | -900 Thousand USD | -80.0% |
| 1993 Q2 | -500 Thousand USD | -150.0% |
| 1993 FY | -2.1 Million USD | -50.0% |
| 1993 Q3 | -500 Thousand USD | 0.0% |
| 1992 Q4 | -800 Thousand USD | -300.0% |
| 1992 Q1 | -100 Thousand USD | 75.0% |
| 1992 Q2 | -200 Thousand USD | -100.0% |
| 1992 FY | -1.4 Million USD | -75.0% |
| 1992 Q3 | -200 Thousand USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 150.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q4 | -400 Thousand USD | -500.0% |
| 1991 Q1 | -200 Thousand USD | 33.33% |
| 1991 FY | -800 Thousand USD | -33.33% |
| 1990 FY | -600 Thousand USD | 33.33% |
| 1990 Q4 | -300 Thousand USD | -200.0% |
| 1990 Q3 | -100 Thousand USD | 0.0% |
| 1990 Q2 | -100 Thousand USD | 50.0% |
| 1990 Q1 | -200 Thousand USD | 60.0% |
| 1989 Q3 | -200 Thousand USD | -300.0% |
| 1989 Q4 | -500 Thousand USD | -150.0% |
| 1989 Q2 | 100 Thousand USD | 200.0% |
| 1989 Q1 | -100 Thousand USD | 93.33% |
| 1989 FY | -900 Thousand USD | 35.71% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -31.91 Million USD | 1.378% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | -230.701% |
| Armata Pharmaceuticals, Inc. | -40.89 Million USD | 23.023% |
| Actinium Pharmaceuticals, Inc. | -51.92 Million USD | 39.376% |
| Azitra, Inc. | -7.61 Million USD | -313.267% |
| Can-Fite BioPharma Ltd. | -8.19 Million USD | -284.089% |
| Chromocell Therapeutics Corporation | -6.86 Million USD | -358.682% |
| Calidi Biotherapeutics, Inc. | -28.99 Million USD | -8.568% |
| iBio, Inc. | -16.63 Million USD | -89.227% |
| Lineage Cell Therapeutics, Inc. | -24.73 Million USD | -27.263% |
| MAIA Biotechnology, Inc. | -20.18 Million USD | -55.958% |
| Matinas BioPharma Holdings, Inc. | -23.76 Million USD | -32.442% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | -124.015% |
| NovaBay Pharmaceuticals, Inc. | -5 Million USD | -529.144% |
| NanoViricides, Inc. | -8.51 Million USD | -269.606% |
| Oragenics, Inc. | -20.9 Million USD | -50.568% |
| BiomX Inc. | -27.68 Million USD | -13.694% |
| BiomX Inc. | -27.68 Million USD | -13.694% |
| Protalix BioTherapeutics, Inc. | 10.46 Million USD | 400.918% |
| Palatin Technologies, Inc. | -22.49 Million USD | -39.918% |
| Scorpius Holdings, Inc. | -42.03 Million USD | 25.114% |
| Theriva Biologics, Inc. | -21.43 Million USD | -46.872% |